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The author apologizes for an error in the *y*-axes of Fig. 5B, D and F.

This has been corrected.

![**Amyloid-β attenuation decreases tau pathology in a brain region-dependent manner.** Tau pathology was assessed in TgF344-AD rats (Tg, Tg-SI) by immunostaining with PHF1 to label hyperphosphorylated tau at S396/404 and Thioflavin-S (Thio-S) to label amyloid-β plaques. (**A**) PHF1+/Thio-S+ staining in the dentate gyrus (DG) of a Tg rat. Approximately 80--85% of PHF1+ inclusions (red) associate with amyloid-β plaques (green), representing dystrophic neurites. \[**A**(**i**)\] The remainder of the tau inclusions are non-plaque associated, representing pretangle inclusions. (**B**) PHF1+ inclusions were separated into plaque and non-plaque associated, and quantified by immunohistochemistry (Supplementary Fig. 7) in the dentate gyrus. Amyloid-β attenuation significantly decreased plaque-associated, but not non-plaque associated inclusions. \[**C** and **C**(**i**)\] PHF1+/Thio-S+ staining in the entorhinal cortex of a Tg rat indicating plaque-associated inclusions and non-plaque associated inclusions. (**D**) There was no effect of treatment on either plaque-associated or non-plaque associated inclusions in the entorhinal cortex (EC) (**E**), despite a reduction of amyloid-β plaques in the region. (**F**) No significant differences were detected in the number of total entorhinal cortical neurons across genotype and treatment (**G**); however, Tg and Tg-SI rats exhibit a decrease of neurons within layer II of the entorhinal cortex. Scale bars = 20 μm in **A** and **C**; 10 μm in **A**(**i**) and **C**(**i**). *n* = 6, mean ± SEM, two-sided unpaired *t*-test, \*\*\**P* \< 0.001.](awz409f1){#awz409-F1}
